Global Fund and U.S. Expand Commitment to Long-Acting HIV Prevention as Country Rollout of Lenacapavir Accelerates
Geneva/Washington, D.C. – The United States and the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) today [April 14] announced an expanded commitment to scale up access to long-acting lenacapavir (LEN) for HIV pre-exposure …